Trevi Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Rosalind Advisors, Inc.(1.34%),Steven Salamon(1.34%)等
04/25 19:41 (美东)
Trevi Therapeutics | 4:持股变动声明-高管 Simon Farrell
02/16 16:48 (美东)
Trevi Therapeutics | 4:持股变动声明-高管 Galletta Christopher
02/16 16:48 (美东)
Trevi Therapeutics | 4:持股变动声明-高管 Clark David J
02/16 16:47 (美东)
Trevi Therapeutics | 4:持股变动声明-高管 GOOD JENNIFER L
02/16 16:47 (美东)
Trevi Therapeutics | 4:持股变动声明-高管 SCIASCIA THOMAS
02/16 16:47 (美东)
Trevi Therapeutics | 4:持股变动声明-高管 Delfini Lisa
02/16 16:47 (美东)
Trevi Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(9.99%),VHCP Co-Investment Holdings II, LLC(9.99%)等
02/14 20:48 (美东)
Trevi Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(0.0%),Peter Harwin(0.0%)等
02/14 15:55 (美东)
Trevi Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Viking Global Investors LP(9.99%),Viking Global Opportunities Parent GP LLC(9.99%)等
02/14 10:27 (美东)
Trevi Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Rubric Capital Management LP(8.90%),David Rosen(8.90%)
02/12 07:07 (美东)
Trevi Therapeutics | 4:持股变动声明-首席财务官 Delfini Lisa
2023/10/12 16:00 (美东)
Trevi Therapeutics | 4:持股变动声明-首席财务官 Delfini Lisa
2023/09/13 16:06 (美东)
Trevi Therapeutics | 4:持股变动声明-首席财务官 Delfini Lisa
2023/08/14 16:00 (美东)
Trevi Therapeutics | 4:持股变动声明-首席财务官 Delfini Lisa
2023/07/12 16:29 (美东)
Trevi Therapeutics | 4:持股变动声明-董事 Mathers Edward T
2023/06/30 16:14 (美东)
Trevi Therapeutics | 4:持股变动声明-董事 Cassella James V
2023/06/30 16:00 (美东)
Trevi Therapeutics | 4:持股变动声明-董事 Heffernan Michael Thomas
2023/06/30 16:00 (美东)
Trevi Therapeutics | 4:持股变动声明-董事 Meeker David P
2023/06/30 16:00 (美东)
Trevi Therapeutics | 4:持股变动声明-董事 Colangelo Dominick
2023/06/30 16:00 (美东)
暂无数据
暂无数据